Publications March 24, 2023
Cardio-Phoenix is applying for Real-World Evaluation of Cardio-HART for Diagnosis of Cardiovascular Conditions under NIHR i4i Challenge Funding
Cardio-Phoenix is proposing a real-world evaluation (RWE) of Cardio-HART, a cardiac diagnostic system, under the NIHR funding competition i4i Challenge.
Publications January 16, 2023
Detecting heart failure using novel bio-signals and a knowledge enhanced neural network
Using an AI solution to process ECG and novel bio-signals, the CHART algorithms are able to predict structural, functional, and valve abnormalities, effectively reducing this diagnostic gap, thereby allowing for the early detection of most common heart diseases and HF in primary care.
Publications November 21, 2022
A tech approach to a long-term cardiovascular care
Health Tech World
Cardiovascular Disease (CVD) was flagged by the NHS as the most prominent condition in which lives could be saved – with plans of preventing 150,000 heart attacks over a decade. What does the technology look like which can achieve this?
Publications October 27, 2022
Detecting Heart Failure using novel bio-signals and a Knowledge Enhanced Neural Network
Background Clinical decisions about Heart Failure (HF) are frequently based on measurements of left ventricular ejection fraction (LVEF), relying mainly on echocardiography measurements for evaluating structural and functional abnormalities of heart disease.
Publications October 24, 2022
Unraveling diagnostic co-morbidity makeup of each HF category as characteristically derived by ECG- and ECHO-findings
Background Echocardiography (ECHO) is not widely available in primary care, the key structural (chamber enlargements) and functional abnormality are not easily available precluding the ability to diagnose HF other than through mainly symptomatic means. The opportunity for earlier detection of HF is lost.
Publications February 10, 2022
Novel tech throws knock-out punch to ECG improving GP referral decisions to cardiology
Cardio-HART is the clinician’s AI-powered heart diagnostic assistant. Early detection of heart disease can prolong or increase a patient's quality of life. In addition, it will reduce the burden on the health system and create better communication between GPs and cardiologists.
Publications December 14, 2020
Cardio-Phoenix secures CE Mark for AI-powered heart diagnostic
Cardio-Phoenix recently announced that it received CE Mark approval for its Cardio-Heart heart disease diagnostic device.
Publications December 11, 2020
Telemedicina cardiaca, arriva il dispositivo CHART che rileva il 95% di tutte le malattie del cuore
CE-marked approval could change the work of specialists and allow them, at the end of the pandemic, to manage the wave of new heart patients.
Publications August 7, 2020
Telemedicina per il cuore post-Covid-19
The great challenge to SARS-CoV-2 virus infection is played out on the ground, through the early identification of new infections and the identification of those at greater risk, such as people with confirmed cardiovascular diseases or risk factors, such as hypertension or obesity.
Publications August 7, 2020
Q&A: Technology aiming to improve detection of heart disease
Ian Bolland caught up with Marc Bisnaire, CEO of Cardio Phoenix to talk about its technology designed to improve the detection of heart disease during and after COVID-19.
Publications February 10, 2020
Listo CADECI 2020 en Guadalajara con innovación en cardiología
An ECG is a test that analyzes the electrical activity of your heart. The test (approx 10 min) involves a technician attaching twelve leads to your chest and then getting a 12-line printout that reflects your heart’s activity during a 10-sec window. So, what does an EKG tell you about your heart’s health?